SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Avadel AVDL -- Ignore unavailable to you. Want to Upgrade?

To: sammaster who wrote (206)10/24/2007 9:32:25 AM
From: sammaster  Respond to of 240
 
i got pretty close with simplistic calculations..

gsk states 31mil pounds= @ 62 million dollars of coreg cr sales

my guess for next quarter based on current run rate
for coreg cr of about 45k scripts= $75million

im sure the launch of coreg generic was brutal but hopefully the furhter we get out from that the more slaes will pick up, so about revenue target could go up

lets see what gsk says in their CC



To: sammaster who wrote (206)10/24/2007 10:18:23 AM
From: Robohogs  Read Replies (2) | Respond to of 240
 
They fell from that week but note the week rkrw reported had Columbus Day so sales were in line with drops in other drugs.

Jon


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News